BioCryst Pharmaceuticals, Inc. (BO1.F) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close7.38

Open7.25

Day range—

52-week range5.1810.19

Off day high0.00%

Off 52-week high−28.84%

Volume106

Avg. volume (3M)71.00

Market cap1.85B

EPS (TTM)-1.10

Forward P/E-9.79

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)0.51

Shares outstanding255.54M

Short interest—

Earnings dateNov 4, 2026

Analyst target—

Profit margin−40.90%

Against its peers

Compare in full ›

	BO1.F	B6E.F	NBIX	AKBA	2096.HK	PHVS
Market cap	1.85B	15.44B	16.81B	192.51M	28.55B	2.41B
P/E (TTM)	—	25.6	24.6	—	16.4	—
Forward P/E	-9.8	—	13.9	-1.9	12.1	-11.2
Price/book	-14.6	0.4	4.3	7.6	2.6	7.1
Dividend yield	—	—	—	—	1.92%	—
1-year change	+20.46%	+44.42%	+7.27%	−65.75%	−16.51%	+57.48%
Today	−1.84%	+1.98%	+0.73%	−4.28%	+3.71%	−1.29%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to BioCryst Pharmaceuticals's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Swedish Orphan Biovitrum AB (publ)B6E.F · Drug Manufacturers - Specialty & Generic	15.44B	44.36	+1.98%
Neurocrine Biosciences, Inc.NBIX · Drug Manufacturers - Specialty & Generic	16.81B	166.05	+0.73%
Akebia Therapeutics, Inc.AKBA · Drug Manufacturers - Specialty & Generic	192.51M	0.6947	−4.28%
Simcere Pharmaceutical Group Limited2096.HK · Drug Manufacturers - Specialty & Generic	28.55B	11.170	+3.71%
Pharvaris N.V.PHVS · Biotechnology	2.41B	34.33	−1.29%
Pharming Group N.V.PHAR · Biotechnology	881.90M	12.46	−3.63%
BioArctic AB (publ)B9A.F · Biotechnology	2.45B	27.58	−0.29%
Biohaven Ltd.BHVN · Biotechnology	2.30B	15.24	−2.37%

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company	Mkt cap	Price	Today
Xeris Biopharma Holdings, Inc.XERS · Chicago, IL	1.91B	10.46	+1.06%
Brooks Laboratories LimitedBROOKS.NS · Mumbai, India	1.96B	66.45	+1.47%
CPBIO Holding Company Limited3839.HK · Central, Hong Kong	1.88B	7.800	+0.26%
Dermapharm Holding SEDMP.F · Grünwald, Germany	1.93B	38.95	+1.17%
Kerala Ayurveda LimitedKERALAYUR.BO · Aluva, India	2.02B	147.75	+2.36%
Gennex Laboratories LimitedGENNEX.BO · Hyderabad, India	2.25B	9.25	−1.39%
Nectar Lifesciences LimitedNECLIFE.NS · Chandigarh, India	1.98B	10.20	−0.58%
Green Thumb Industries Inc.GTII.CN · Chicago, IL	2.00B	9.13	−3.79%

Healthcare companies of a similar market value (1.89B).

Company	Mkt cap	Price	Today
BioLife Solutions IncBLFS · Medical Instruments & Supplies	1.89B	38.61	0.00%
Xeris Biopharma Holdings, Inc.XERS · Drug Manufacturers - Specialty & Generic	1.91B	10.46	+1.06%
Vir Biotechnology, Inc.VIR · Biotechnology	1.99B	11.77	+4.90%
Precigen, Inc.PGEN · Biotechnology	1.81B	5.06	−3.71%
Alamar Biosciences, Inc.ALMR · Medical Devices	1.90B	27.39	−9.36%
Agios Pharmaceuticals, Inc.AGIO · Biotechnology	1.87B	31.38	+0.58%
Brooks Laboratories LimitedBROOKS.NS · Drug Manufacturers - Specialty & Generic	1.96B	66.45	+1.47%
CPBIO Holding Company Limited3839.HK · Drug Manufacturers - Specialty & Generic	1.88B	7.800	+0.26%

Also based in Durham, North Carolina, then elsewhere in North Carolina.

Company	Mkt cap	Price	Today
IQVIA Holdings Inc.IQV · Durham, NC	43.47B	263.79	+0.46%
Immunovant, Inc.IMVT · Durham, NC	6.18B	29.90	+2.96%
Fortrea Holdings Inc.FTRE · Durham, NC	2.01B	20.83	−0.57%
Wolfspeed, Inc.WOLF · Durham, NC	1.21B	22.79	+1.65%
Bioventus Inc.BVS · Durham, NC	781.98M	11.42	+4.34%
Opus Genetics, Inc.IRD · Durham, NC	355.25M	4.2700	+8.65%
Precision BioSciences, Inc.DTIL · Durham, NC	226.84M	8.12	+16.50%
Humacyte, Inc.HUMA · Durham, NC	125.01M	0.4500	+2.16%

Companies that serve the same markets: life sciences, industrial.

Company	Mkt cap	Price	Today
Everest Organics LimitedEVERESTO.BO · life sciences · industrial	2.40B	241.05	+0.48%
Zenotech Laboratories LimitedZENOTECH.BO · life sciences · industrial	2.34B	38.41	−0.34%
PolyPeptide Group AGPPGN.SW · life sciences · industrial	1.36B	41.05	−0.73%
Zhongzhi Pharmaceutical Holdings Limited3737.HK · life sciences · industrial	540.00M	0.640	0.00%
Zhejiang Xianju Pharmaceutical Co., Ltd.002332.SZ · life sciences · industrial	8.91B	9.01	+0.11%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.002399.SZ · life sciences · industrial	14.09B	9.60	+1.80%
Lifecore Biomedical, Inc.LDE.F · life sciences · industrial	210.38M	5.55	−0.89%
Beryl Drugs LimitedBERLDRG.BO · life sciences · industrial	126.79M	25.00	+7.57%

What visitors to BioCryst Pharmaceuticals's page also look at.

Company	Mkt cap	Price	Today
Novavax Inc.NVV1.F	1.60B	9.72	+5.08%
ON SEMICONDUCTOR CORP.XS4.F	24.11B	61.94	−3.70%
GILEAD SCIENCES INC.GIS.F	191.58B	154.46	+0.89%
Akebia Therapeutics Inc.AX9.F	165.49M	0.5972	−5.12%
Shanghai Fos.Pharm.(Gr.)Co.LtdR08HH.F	5.17B	1.9345	+1.79%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All BO1.F news ›

Seeking Alpha·15h ago·2 outletsPositive

BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2026 Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2026 Earnings Call November 4, 2026 8:30 AM EST Nick Wilder - Manager of Investor RelationsCharles Gayer - CEO, President & DirectorBabar Ghias - CFO & Head of Corporate DevelopmentSandeep Menon -…

BIIB WFC

BioCryst Pharmaceuticals (NASDAQ:BCRX) Upgraded at Wall Street Zen

Posted by Kim Johansen on Oct 27th, 2026 Wall Street Zen upgraded shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday,Wall Street Zen…

BCRX BIIB LBRX BCAX

Mugglehead·Oct 21Negative

BioCryst Pharmaceuticals wins FDA approval for 150 mg ORLADEYO pellets

Patients aged 12 and older gain an alternative to capsules, while the approval release gives no launch date for the new strength. An alternative to daily capsules will broaden hereditary angioedema (HAE) prevention options as BioCryst…

NVO UNCY LLY

Defense World·Oct 21Positive

Contrasting BioCryst Pharmaceuticals (NASDAQ:BCRX) & Syndax Pharmaceuticals (NASDAQ:SNDX)

Posted by Defense World Staff on Oct 21st, 2026 BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Free Report) and Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) are both healthcare companies, but which is the better business? We will…

BDTX NRXP BSX BMRA

MarketScreener·Oct 5

Biocryst Pharmaceuticals, Inc. Announces Formation of Scientific Advisory Board

Biocryst Pharmaceuticals, Inc.

BCRX PFE

From the 4Search news index, newest first.

In the news

5mentions in 30 days

5with it in the headline

Positivesentiment

Most coverage from

themarketsdaily.com2
defenseworld.net1
mugglehead.com1
seekingalpha.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.